{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:54:12Z","timestamp":1793656452231,"version":"4.5.1"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>With growing myopia prevalence worldwide, effective strategies to prevent early-onset myopia are needed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the efficacy of diversified segmental defocus optimization (DSDO) spectacle lenses with or without 0.01% atropine for myopia prevention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This was 1-year randomized placebo-controlled double-masked clinical trial conducted in the Department of Ophthalmology at Peking University People\u2019s Hospital from November 2023 to December 2024. Children aged 5 to 12 years with spherical equivalent refraction (SER) of 0.00 to 1.00 diopters (D) after cycloplegia were included, excluding those with ocular diseases, systemic diseases, or previous use of optical or pharmaceutical myopia control methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>Participants were randomly assigned in a 1:1:1 ratio to receive DSDO spectacles with placebo eye drops (DSDO group), DSDO spectacles with 0.01% atropine eye drops (DSDOA group), or single-vision spectacles with placebo eye drops (control group).<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The primary outcomes were the cumulative incidence rate of myopia (defined as SER \u2264\u22120.50 D) and the percentage of participants with fast myopic shift (defined as a spherical equivalent myopic shift \u22650.50 D) over 1 year. Secondary outcomes included changes in SER, axial length, and subfoveal choroidal thickness.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 450 children initially randomized (DSDO group: mean [SD] age, 7.05 [0.12] years; 77 [51.3%] male; DSDOA group: mean [SD] age, 7.02 [0.14] years; 73 [48.7%] male; control group: mean [SD] age, 7.01 [0.11] years; 78 [52.0%] male), 370 (82.2%) completed the study, including 121 in the DSDO group, 125 in the DSDOA group, and 124 in the control group. The 1-year cumulative incidence rates of myopia in the DSDO, DSDOA, and control groups were 5.8% (7\/121), 4.8% (6\/125), and 15.3% (19\/124), respectively, and the percentages of participants with fast myopic shift after 1 year were 15.7% (19\/121), 9.6% (12\/125), and 42.7% (53\/124). Both DSDO and DSDOA groups showed significantly lower 1-year cumulative myopia incidence (DSDO: difference, 9.5%; 95% CI, 1.9-17.5; <jats:italic>P<\/jats:italic>\u2009=\u2009.02; DSDOA: difference, 10.5%; 95% CI, 3.3-18.4; <jats:italic>P<\/jats:italic>\u2009=\u2009.006) and the percentage of patients with fast myopic shift (DSDO: difference, 27.0%; 95% CI, 16.1-37.3; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001; DSDOA: difference, 33.1%; 95% CI, 23.1-42.8; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) vs control. No significant differences were observed between DSDO and DSDOA groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Relevance<\/jats:title><jats:p>These data suggest that daily use of DSDO spectacles delays the onset of myopia among children without myopia, supporting DSDO spectacles without atropine as an alternative preventive method for children without myopia if supported with longer follow-up and replication by others.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>Chinese Clinical Trial Registry: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/showproj.html?proj=209971\">ChiCTR2300077307<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2025.2072","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T15:00:37Z","timestamp":1752159637000},"page":"684","source":"Crossref","is-referenced-by-count":9,"title":["Diversified Segmental Defocus Optimization Lenses With and Without Atropine for Myopia Prevention"],"prefix":"10.1001","volume":"143","author":[{"given":"Yuchang","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Institute of Medical Technology, Peking University Health Science Center, Beijing, China"},{"name":"Beijing Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing, China"},{"name":"College of Optometry, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[{"name":"Peking University International Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing, China"},{"name":"College of Optometry, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing, China"},{"name":"College of Optometry, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Institute of Medical Technology, Peking University Health Science Center, Beijing, China"},{"name":"Beijing Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing, China"},{"name":"College of Optometry, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqi","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Institute of Medical Technology, Peking University Health Science Center, Beijing, China"},{"name":"Beijing Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing, China"},{"name":"College of Optometry, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Beijing Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing, China"},{"name":"College of Optometry, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Institute of Medical Technology, Peking University Health Science Center, Beijing, China"},{"name":"Beijing Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing, China"},{"name":"College of Optometry, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking University People\u2019s Hospital, Beijing, China"},{"name":"Institute of Medical Technology, Peking University Health Science Center, Beijing, China"},{"name":"Beijing Key Laboratory of Ocular Disease and Optometry Science, Peking University People\u2019s Hospital, Beijing, China"},{"name":"College of Optometry, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"eoi250033r1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050.","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"eoi250033r2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","article-title":"The epidemics of myopia: aetiology and prevention.","volume":"62","author":"Morgan","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"eoi250033r3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/opo.12305","article-title":"Age of onset of myopia predicts risk of high myopia in later childhood in myopic Singapore children.","volume":"36","author":"Sy","year":"2016","journal-title":"Ophthalmic Physiol Opt"},{"issue":"11","key":"eoi250033r4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/jamaophthalmol.2020.3451","article-title":"Association of age at myopia onset with risk of high myopia in adulthood in a 12-year follow-up of a Chinese cohort.","volume":"138","author":"Hu","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"eoi250033r5","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.ophtha.2021.04.032","article-title":"The risks and benefits of myopia control.","volume":"128","author":"Bullimore","year":"2021","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi250033r6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ophtha.2018.10.029","article-title":"Potential lost productivity resulting from the global burden of myopia: systematic review, meta-analysis, and modeling.","volume":"126","author":"Naidoo","year":"2019","journal-title":"Ophthalmology"},{"key":"eoi250033r7","doi-asserted-by":"publisher","first-page":"11003","DOI":"10.7189\/jogh.12.11003","article-title":"Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study.","volume":"12","author":"Ma","year":"2022","journal-title":"J Glob Health"},{"issue":"11","key":"eoi250033r8","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","article-title":"Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial.","volume":"53","author":"Cho","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"eoi250033r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2024.102167","article-title":"Effectiveness of orthokeratology and myopia control spectacles in a real-world setting in China.","volume":"47","author":"Yang","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"issue":"6","key":"eoi250033r10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jama.2020.10834","article-title":"Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children: the BLINK randomized clinical trial.","volume":"324","author":"Walline","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"eoi250033r11","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1136\/bjophthalmol-2020-317664","article-title":"Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study.","volume":"106","author":"Lam","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi250033r12","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","article-title":"Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial","volume":"140","author":"Bao","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"eoi250033r13","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/jamaophthalmol.2023.2097","article-title":"Efficacy and safety of 0.01% and 0.02% atropine for the treatment of pediatric myopia progression over 3 years: a randomized clinical trial.","volume":"141","author":"Zadnik","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"eoi250033r14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10384-021-00822-y","article-title":"Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study.","volume":"65","author":"Hieda","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"eoi250033r15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jama.2022.24162","article-title":"Effect of low-concentration atropine eyedrops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial.","volume":"329","author":"Yam","year":"2023","journal-title":"JAMA"},{"issue":"22","key":"eoi250033r16","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1111\/bph.15629","article-title":"Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release.","volume":"178","author":"Thomson","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"8","key":"eoi250033r17","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1167\/iovs.09-4969","article-title":"Effects of optical defocus on refractive development in monkeys: evidence for local, regionally selective mechanisms.","volume":"51","author":"Smith","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi250033r18","doi-asserted-by":"publisher","first-page":"22311","DOI":"10.1038\/s41598-022-25599-z","article-title":"Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia.","volume":"12","author":"Huang","year":"2022","journal-title":"Sci Rep"},{"issue":"11","key":"eoi250033r19","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1167\/iovs.05-0445","article-title":"Peripheral vision can influence eye growth and refractive development in infant monkeys.","volume":"46","author":"Smith","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"eoi250033r20","first-page":"405","article-title":"Controlling progression of myopia: optical and pharmaceutical strategies.","volume":"7","author":"Sankaridurg","year":"2018","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"3","key":"eoi250033r21","doi-asserted-by":"publisher","first-page":"M106","DOI":"10.1167\/iovs.18-25958","article-title":"IMI - Interventions Myopia Institute: interventions for controlling myopia onset and progression report.","volume":"60","author":"Wildsoet","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi250033r22","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","article-title":"Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: a randomized clinical trial.","volume":"140","author":"Bao","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"eoi250033r23","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.ophtha.2024.07.002","article-title":"Novel lenslet-array-integrated spectacle lenses for myopia control: a 1-year randomized, double-masked, controlled trial.","volume":"131","author":"Su","year":"2024","journal-title":"Ophthalmology"},{"issue":"7","key":"eoi250033r24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/aos.14773","article-title":"The influence of the choroid on the onset and development of myopia: from perspectives of choroidal thickness and blood flow.","volume":"99","author":"Liu","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"eoi250033r25","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/bjo-2022-321272","article-title":"Effect of atropine, orthokeratology and combined treatments for myopia control: a 2-year stratified randomised clinical trial.","volume":"107","author":"Xu","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi250033r26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/opo.12722","article-title":"One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial.","volume":"40","author":"Tan","year":"2020","journal-title":"Ophthalmic Physiol Opt"},{"issue":"9","key":"eoi250033r27","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s41433-024-02987-5","article-title":"Comparison of the long-term effects of atropine in combination with Orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents.","volume":"38","author":"Tang","year":"2024","journal-title":"Eye (Lond)"},{"issue":"6","key":"eoi250033r28","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s10792-021-01755-8","article-title":"Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study.","volume":"41","author":"Joachimsen","year":"2021","journal-title":"Int Ophthalmol"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2835950\/jamaophthalmology_lu_2025_oi_250033_1754685051.81513.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T15:00:49Z","timestamp":1755788449000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2835950"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2025.2072","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}